Oligodendrocyte progenitor cell explained

Oligodendrocyte progenitor cell
Caption:NG2-positive oligodendrocyte progenitor cells (green) and GFAP-positive astrocytes (red) in culture.
Acronym:OPC

Oligodendrocyte progenitor cells (OPCs), also known as oligodendrocyte precursor cells, NG2-glia, O2A cells, or polydendrocytes, are a subtype of glia in the central nervous system named for their essential role as precursors to oligodendrocytes and myelin.[1] They are typically identified in the human by co-expression of PDGFRA and CSPG4.

OPCs play a critical role in developmental and adult myelinogenesis. They give rise to oligodendrocytes, which then wrap around axons and provide electrical insulation by forming a myelin sheath. This enables faster action potential propagation and high fidelity transmission without a need for an increase in axonal diameter.[2] The loss or lack of OPCs, and consequent lack of differentiated oligodendrocytes, is associated with a loss of myelination and subsequent impairment of neurological functions.[3] In addition, OPCs express receptors for various neurotransmitters and undergo membrane depolarization when they receive synaptic inputs from neurons.

Structure

OPCs are glial cells that are typically identified by co-expression of NG2 (a chondroitin sulfate proteoglycan encoded by CSPG4 in humans) and platelet-derived growth factor receptor alpha (encoded by PDGFRA).[4] They are smaller than neurons, of comparable size to other glia, and can either have a bipolar or complex multipolar morphology with processes reaching up to ~50 μm.[5] OPCs comprise approximately 3–4% of cells in grey matter and 8–9% in white matter, making them the fourth largest group of glia after astrocytes, microglia and oligodendrocytes.[6]

OPCs are present throughout the brain, including the hippocampus and in all layers of the neocortex.[7] They distribute themselves and achieve a relatively even distribution through active self-repulsion.[5] [8] OPCs constantly survey their surroundings through actively extending and retracting processes that have been termed growth cone like processes.[9] Death or differentiation of an OPC is rapidly followed by migration or local proliferation of a neighboring cell to replace it.

In white matter, OPCs are found along unmyelinated axons[10] as well as along myelinated axons, engulfing nodes of Ranvier.[11] [12] Recently, OPCs have been shown to reside in close contact with NG2-expressing pericytes in cerebral white matter, as well.[13]

OPCs receive synaptic contacts onto their processes from both glutamatergic[14] and GABAergic neurons.[15] OPCs receive preferred somatic contacts from fast-spiking GABAergic neurons, while non-fast spiking interneurons have a preference for contacting the processes.[16] These inhibitory connections (in mice) occur mainly during a specific period in development, from postnatal day 8 till postnatal day 13.

Development

OPCs first appear during embryonic organogenesis. In the developing neural tube, Shh (Sonic hedgehog) signaling and expression of Nkx6.1/Nkx6.2 coordinate expression of Olig1 and Olig2 in neuroepithelial cells of the pMN and p3 domains of the ventral ventricular zone.[17] [18] [19] Together, Nkx2.2 and Olig1/Olig2 drive OPC specification.[20] [21]

In the forebrain, three regionally distinct sources have been shown to generate OPCs sequentially. OPCs first originate from Nkx2.1-expressing cells in the ventricular zone of the medial ganglionic eminence.[22] [23] [24] Some OPCs are also generated from multipotent progenitors in the subventricular zone (SVZ). These cells migrate into the olfactory bulb.[25] Depending on their origin in the SVZ, these progenitors give rise to either OPCs or astrocytes. Typically, cells originating from the posterior and dorsomedial SVZ produce more oligodendrocytes owing to increased exposure to posterior Shh signaling and dorsal Wnt signaling which favors OPC specification, in contrast to ventral Bmp signaling which inhibits it.[26] [27]

As development progresses, second and third waves of OPCs originate from Gsh2-expressing cells in the lateral and caudal ganglionic eminences and generate the majority of adult oligodendrocytes.[22] After the committed progenitor cells exit the germinal zones, they migrate and proliferate locally to eventually occupy the entire CNS parenchyma. OPCs are highly proliferative, migratory, and have bipolar morphology.[28]

OPCs continue to exist in both white and grey matter in the adult brain and maintain their population through self-renewal.[29] [30] White matter OPCs proliferate at higher rates and are best known for their contributions to adult myelinogenesis, while grey matter OPCs are slowly proliferative or quiescent and mostly remain in an immature state.[31] [32] Subpopulations of OPCs have different resting membrane potentials, ion channel expression, and ability to generate action potentials.[33]

Fate

See main article: Myelinogenesis. Typically beginning in postnatal development, OPCs myelinate the entire central nervous system (CNS).[34] They differentiate into the less mobile premyelinating oligodendrocytes that further differentiate into oligodendrocytes,[35] a process characterized by the emergence of the expression of myelin basic protein (MBP), proteolipid protein (PLP), or myelin-associated glycoprotein (MAG). Following terminal differentiation in vivo, mature oligodendrocytes wrap around and myelinate axons. In vitro, oligodendrocytes create an extensive network of myelin-like sheets. The process of differentiation can be observed both through morphological changes and cell surface markers specific to the discrete stage of differentiation, though the signals for differentiation are unknown.[36] The various waves of OPCs could myelinate distinct regions of the brain, which suggests that distinct functional subpopulations of OPCs perform different functions.[37]

Differentiation of OPCs into oligodendrocytes involves massive reorganization of cytoskeleton proteins ultimately resulting in increased cell branching and lamella extension, allowing oligodendrocytes to myelinate multiple axons. Multiple pathways contribute to oligodendrocyte branching, but the exact molecular process by which oligodendrocytes extend and wrap around multiple axons remains incompletely understood. Laminin, a component of the extracellular matrix, plays an important role in regulating oligodendrocyte production. Mice lacking laminin alpha2-subunit produced fewer OPCs in the subventricular zone (SVZ).[38] Deletion of Dicer1 disrupts normal brain myelination. However, miR-7a, and miRNA in OPCs, promotes OPC production during brain development.[39]

Controversy

The possibility and in vivo relevance of OPC differentiation into astrocytes or neurons are highly debated.[1] Using Cre-Lox recombination-mediated genetic fate mapping, several labs have reported the fate of OPCs using different Cre driver and reporter mouse lines.[40] It is generally held that OPCs predominantly generate oligodendrocytes, and the rate at which they generate oligodendrocytes declines with age and is greater in white matter than in grey matter. Up to 30% of the oligodendrocytes that exist in the adult corpus callosum are generated de novo from OPCs over a period of 2 months. It is not known whether all OPCs eventually generate oligodendrocytes while self-renewing the population, or whether some remain as OPCs throughout the life of the animal and never differentiate into oligodendrocytes.[41]

OPCs may retain the ability to differentiate into astrocytes into adulthood.[42] [43] Using NG2-Cre mice, it was shown that OPCs in the prenatal and perinatal grey matter of the ventral forebrain and spinal cord generate protoplasmic type II astrocytes in addition to oligodendrocytes. However, contrary to the prediction from optic nerve cultures, OPCs in white matter do not generate astrocytes. When the oligodendrocyte transcription factor Olig2 is deleted specifically in OPCs, there is a region- and age-dependent switch in the fate of OPCs from oligodendrocytes to astrocytes.[44]

Whereas some studies suggested that OPCs can generate cortical neurons,[45] other studies rejected these findings.[46] The question is unresolved, as studies continue to find that certain populations of OPCs can form neurons.[47] In conclusion, these studies suggest that OPCs do not generate a significant number of neurons under normal conditions, and that they are distinct from neural stem cells that reside in the subventricular zone.[48]

Function

As implied by their name, OPCs were long held to function purely as progenitors to oligodendrocytes. Their role as a progenitor cell type has since expanded to include both oligodendrocytes and some protoplasmic type II astrocytes in grey matter.[43] Later, additional functions were suggested.

Remyelination

Spontaneous myelin repair was first observed in cat models.[49] It was later discovered to occur in the human CNS as well, specifically in cases of multiple sclerosis (MS).[50] Spontaneous myelin repair does not result in morphologically normal oligodendrocytes and is associated with thinner myelin compared to axonal diameter than normal myelin.[51] Despite morphological abnormalities, however, remyelination does restore normal conduction.[52] In addition, spontaneous remyelination does not appear to be rare, at least in the case of MS. Studies of MS lesions reported the average extent of remyelination as high as 47%.[53] Comparative studies of cortical lesions reported a greater proportion of remyelination in the cortex as opposed to white matter lesions.

OPCs retain the ability to proliferate in adulthood and comprise 70–90% of the proliferating cell population in the mature CNS.[6] [54] Under conditions in the developing and mature CNS where a reduction in the normal number of oligodendrocytes or myelin occurs, OPCs react promptly by undergoing increased proliferation. Rodent OPCs proliferate in response to demyelination in acute or chronic lesions created by chemical agents such as lysolecithin, and newborn cells differentiate into remyelinating oligodendrocytes.[55] [56] A chelating agent cuprizone is also used in these demyelination studies in rats.[57] Similarly, OPC proliferation occurs in other types of injury that are accompanied by loss of myelin, such as spinal cord injury.[58]

Despite OPCs' potential to give rise to myelinating oligodendrocytes, complete myelin regeneration is rarely observed clinically or in chronic experimental models. Possible explanations for remyelination failure include depletion of OPCs over time, failure to recruit OPCs to the demyelinated lesion, and failure of recruited OPCs to differentiate into mature oligodendrocytes (reviewed in[59] [60] [61]). In fresh MS lesions, clusters of HNK-1+ oligodendrocytes have been observed,[62] which suggests that under favorable conditions OPCs expand around demyelinated lesions and generate new oligodendrocytes. In chronic MS lesions where remyelination is incomplete, there is evidence that there are oligodendrocytes with processes extending toward demyelinated axons, but they do not seem to be able to generate new myelin.[63] The mechanisms that regulate differentiation of OPCs into myelinating oligodendrocytes are an active area of research.

Another unanswered question is whether the OPC pool eventually becomes depleted after it is used to generate remyelinating cells. Clonal analysis of isolated OPCs in the normal mouse forebrain suggests that in the adult, most clones originating from single OPCs consist of either a heterogeneous population containing both oligodendrocytes and OPCs or a homogeneous population consisting exclusively of OPCs, suggesting that OPCs in the adult CNS are able to self-renew and are not depleted under normal conditions.[64] However, it is not known whether this dynamic is altered in response to demyelinating lesions.

Neuron–OPC interactions

Node of Ranvier

OPCs extend their processes to the nodes of Ranvier[11] and together with astrocyte processes make up the nodal glial complex. Since the nodes of Ranvier contain a high density of voltage-dependent sodium channels and allow regenerative action potentials to be generated, it is speculated that this location allows OPCs to sense and possibly respond to neuronal activity.

Neuromodulation

OPCs synthesize the neuromodulatory factors prostaglandin D2 synthase (PTGDS) and neuronal pentraxin 2 (NPTX2).[65] This is regulated by NG2, whose intracellular domain can be cleaved by γ-secretase[66] [67] and translocated to the nucleus. The NG2 ectodomain can also modulate AMPA and NMDA receptor-dependent LTP. Constitutive and activity-dependent cleavage of NG2 by ADAM10 releases the ectodomain, which contains two N-terminal LNS domains that act on neuronal synapses.[66] [67]

Neuron–OPC synapse

OPCs express numerous voltage-gated ion channels and neurotransmitter receptors.[68] Structural studies have shown that neurons form synapses with OPCs in both grey matter[14] and white matter.[69] Electron microscopy revealed OPC membranes apposed to neuronal presynaptic terminals filled with synaptic vesicles. OPCs express AMPA receptors and GABAA receptors and undergo small membrane depolarizations in response to presynaptic vesicular glutamate or GABA release.

OPCs can undergo cell division while maintaining synaptic inputs from neurons.[70] These observations suggest that cells that receive neuronal synaptic inputs and those that differentiate into oligodendrocytes are not mutually exclusive cell populations but that the same population of OPCs can receive synaptic inputs and generate myelinating oligodendrocytes. However, OPCs appear to lose their ability to respond to synaptic inputs from neurons as they differentiate into mature oligodendrocytes.[71] [72] The functional significance of the neuron-OPC synapses remains to be elucidated.

Immunomodulation

OPCs have been increasingly recognized for their pivotal role in modulating immune responses, particularly in autoimmune diseases such as multiple sclerosis (MS).[73] [74] They may participate in both initiation and resolution of immune responses to disease or injury. They are highly responsive to injury, undergo a morphological activation similar to that of astrocytes and microglia, and may contribute to glial scar formation.[75] Conversely, OPCs have been shown to downregulate microglia activation and protect against neuronal death.[76] They also express and secrete many immune-related molecules, such as chemokines, cytokines, interleukins, and other related ligands or receptors.[77] OPCs can internalize myelin debris via phagocytosis, a process mediated through the LRP-1 pathway.[78] [79] Furthermore, recent works have illustrated that OPCs can act as antigen presenting cells via both MHC class I and class II and can modulate both CD4+ and CD8+ T cells.[80] [81] [82]

Clinical significance

Transplantation of OPCs has been considered as a possible treatment for neurological diseases which cause demyelination. However, it is difficult to generate a suitable number of quality cells for clinical use. Finding a source for these cells remains impractical as of 2016. Should adult cells be used for transplantation, a brain biopsy would be required for each patient, adding to the risk of immune rejection. Embryonically derived stem cells have been demonstrated to carry out remyelination under laboratory conditions, but some religious groups are opposed to their use. Adult central nervous system stem cells have also been shown to generate myelinating oligodendrocytes, but are not readily accessible.[83]

Even if a viable source of OPCs were found, identifying and monitoring the outcome of remyelination remains difficult, though multimodal measures of conduction velocity and emerging magnetic resonance imaging techniques offer improved sensitivity versus other imaging methods.[84] In addition, the interaction between transplanted cells and immune cells and the effect of inflammatory immune cells on remyelination have yet to be fully characterized. If the failure of endogenous remyelination is due to an unfavorable differentiation environment, then this will have to be addressed prior to transplantation.

History

It had been known since the early 1900s that astrocytes, oligodendrocytes, and microglia make up the major glial cell populations in the mammalian CNS. The presence of another glial cell population had escaped recognition because of the lack of a suitable marker to identify them in tissue sections. The notion that there exists a population of glial progenitor cells in the developing and mature CNS began to be entertained in the late 1980s by several independent groups. In one series of studies on the development and origin of oligodendrocytes in the rodent CNS, a population of immature cells that appeared to be precursors to oligodendrocytes was identified by the expression of the GD3 ganglioside.[85]

In a separate series of studies, cells from perinatal rat optic nerves that expressed the A2B5 ganglioside were shown to differentiate into oligodendrocytes in culture.[86] Subsequently, A2B5+ cells from other CNS regions and from adult CNS were also shown to generate oligodendrocytes. Based on the observation that these cells require PDGF for their proliferation and expansion, the expression of the alpha receptor for platelet-derived growth factor (Pdgfra) was used to search for the in vivo correlates of the A2B5+ cells, which led to the discovery of a unique population of Pdgfra+ cells in the CNS whose appearance and distribution were consistent with those of developing oligodendrocytes.[87]

Independently, Stallcup and colleagues generated an antiserum that recognized a group of rat brain tumor cell line, which exhibited properties that were intermediate between those of typical neurons and glial cells. Biochemical studies showed that the antiserum recognized a chondroitin sulfate proteoglycan with a core glycoprotein of 300 kDa,[88] and the antigen was named NG2 (nerve/glial antigen 2).[89] [90] NG2 was found to be expressed on A2B5+ oligodendrocyte precursor cells isolated from the perinatal rat CNS tissues and on process-bearing cells in the CNS in vivo.[91] Comparison of NG2 and Pdgfra expression revealed that NG2 and PDGFRA are expressed on the same population of cells in the CNS.[4] These cells represent 2–9% of all the cells and remain proliferative in the mature CNS.[6]

See also

Notes and References

  1. Nishiyama A, Komitova M, Suzuki R, Zhu X . Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity . Nature Reviews. Neuroscience . 10 . 1 . 9–22 . January 2009 . 19096367 . 10.1038/nrn2495 . 15264205 .
  2. Swiss VA, Nguyen T, Dugas J, Ibrahim A, Barres B, Androulakis IP, Casaccia P . Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation . PLOS ONE . 6 . 4 . e18088 . April 2011 . 21490970 . 3072388 . 10.1371/journal.pone.0018088 . Feng Y . free . 2011PLoSO...618088S .
  3. Buller B, Chopp M, Ueno Y, Zhang L, Zhang RL, Morris D, Zhang Y, Zhang ZG . Regulation of serum response factor by miRNA-200 and miRNA-9 modulates oligodendrocyte progenitor cell differentiation . Glia . 60 . 12 . 1906–1914 . December 2012 . 22907787 . 3474880 . 10.1002/glia.22406 .
  4. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB . Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain . Journal of Neuroscience Research . 43 . 3 . 299–314 . February 1996 . 8714519 . 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E . 25711458 .
  5. Hughes EG, Kang SH, Fukaya M, Bergles DE . Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain . Nature Neuroscience . 16 . 6 . 668–676 . June 2013 . 23624515 . 3807738 . 10.1038/nn.3390 .
  6. Dawson MR, Polito A, Levine JM, Reynolds R . NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS . Molecular and Cellular Neurosciences . 24 . 2 . 476–488 . October 2003 . 14572468 . 10.1016/S1044-7431(03)00210-0 . 21910392 .
  7. Ong WY, Levine JM . A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus . Neuroscience . 92 . 1 . 83–95 . 1999 . 10392832 . 10.1016/S0306-4522(98)00751-9 . 10924179 .
  8. Birey F, Aguirre A . Age-Dependent Netrin-1 Signaling Regulates NG2+ Glial Cell Spatial Homeostasis in Normal Adult Gray Matter . The Journal of Neuroscience . 35 . 17 . 6946–6951 . April 2015 . 25926469 . 4412904 . 10.1523/JNEUROSCI.0356-15.2015 .
  9. Michalski JP, Kothary R . Oligodendrocytes in a Nutshell . Frontiers in Cellular Neuroscience . 9 . 340 . 2015 . 26388730 . 4556025 . 10.3389/fncel.2015.00340 . free .
  10. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE . Vesicular release of glutamate from unmyelinated axons in white matter . Nature Neuroscience . 10 . 3 . 321–330 . March 2007 . 17293857 . 2140234 . 10.1038/nn1854 .
  11. Butt AM, Duncan A, Hornby MF, Kirvell SL, Hunter A, Levine JM, Berry M . Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter . Glia . 26 . 1 . 84–91 . March 1999 . 10088675 . 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L . 1688659 .
  12. Miller RH . Oligodendrocyte origins . Trends in Neurosciences . 19 . 3 . 92–96 . March 1996 . 9054062 . 10.1016/S0166-2236(96)80036-1 . 22746971 .
  13. Maki T, Maeda M, Uemura M, Lo EK, Terasaki Y, Liang AC, Shindo A, Choi YK, Taguchi A, Matsuyama T, Takahashi R, Ihara M, Arai K . Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter . Neuroscience Letters . 597 . 164–169 . June 2015 . 25936593 . 4443478 . 10.1016/j.neulet.2015.04.047 .
  14. Bergles DE, Roberts JD, Somogyi P, Jahr CE . Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus . Nature . 405 . 6783 . 187–191 . May 2000 . 10821275 . 10.1038/35012083 . 4422069 . 2000Natur.405..187B .
  15. Steinhäuser C, Gallo V . News on glutamate receptors in glial cells . Trends in Neurosciences . 19 . 8 . 339–345 . August 1996 . 8843603 . 10.1016/0166-2236(96)10043-6 . 31596399 .
  16. Orduz D, Maldonado PP, Balia M, Vélez-Fort M, de Sars V, Yanagawa Y, Emiliani V, Angulo MC . Interneurons and oligodendrocyte progenitors form a structured synaptic network in the developing neocortex . eLife . 4 . April 2015 . 25902404 . 4432226 . 10.7554/eLife.06953 . free .
  17. Ravanelli AM, Appel B . Motor neurons and oligodendrocytes arise from distinct cell lineages by progenitor recruitment . Genes & Development . 29 . 23 . 2504–2515 . December 2015 . 26584621 . 4691953 . 10.1101/gad.271312.115 .
  18. Dessaud E, Ribes V, Balaskas N, Yang LL, Pierani A, Kicheva A, Novitch BG, Briscoe J, Sasai N . Dynamic assignment and maintenance of positional identity in the ventral neural tube by the morphogen sonic hedgehog . PLOS Biology . 8 . 6 . e1000382 . June 2010 . 20532235 . 2879390 . 10.1371/journal.pbio.1000382 . free .
  19. Kim H, Shin J, Kim S, Poling J, Park HC, Appel B . Notch-regulated oligodendrocyte specification from radial glia in the spinal cord of zebrafish embryos . Developmental Dynamics . 237 . 8 . 2081–2089 . August 2008 . 18627107 . 2646814 . 10.1002/dvdy.21620 .
  20. Zhou Q, Choi G, Anderson DJ . The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2 . Neuron . 31 . 5 . 791–807 . September 2001 . 11567617 . 10.1016/s0896-6273(01)00414-7 . free .
  21. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH . Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection . Cell . 109 . 1 . 75–86 . April 2002 . 11955448 . 10.1016/s0092-8674(02)00678-5 . 1865925 . 10.1.1.327.1752 .
  22. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD . Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage . Nature Neuroscience . 9 . 2 . 173–179 . February 2006 . 16388308 . 6328015 . 10.1038/nn1620 .
  23. Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV . Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase . The Journal of Cell Biology . 145 . 6 . 1209–1218 . June 1999 . 10366594 . 2133143 . 10.1083/jcb.145.6.1209 .
  24. Spassky N, Olivier C, Cobos I, LeBras B, Goujet-Zalc C, Martínez S, Zalc B, Thomas JL . The early steps of oligodendrogenesis: insights from the study of the plp lineage in the brain of chicks and rodents . Developmental Neuroscience . 23 . 4–5 . 318–326 . 2001 . 11756747 . 10.1159/000048715 . 46878049 .
  25. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A . Subventricular zone astrocytes are neural stem cells in the adult mammalian brain . Cell . 97 . 6 . 703–716 . June 1999 . 10380923 . 10.1016/s0092-8674(00)80783-7 . 16074660 . free .
  26. Ortega F, Gascón S, Masserdotti G, Deshpande A, Simon C, Fischer J, Dimou L, Chichung Lie D, Schroeder T, Berninger B . Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling . Nature Cell Biology . 15 . 6 . 602–613 . June 2013 . 23644466 . 10.1038/ncb2736 . free . 23154014 . 10261/346164 .
  27. Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A . Origin of oligodendrocytes in the subventricular zone of the adult brain . The Journal of Neuroscience . 26 . 30 . 7907–7918 . July 2006 . 16870736 . 6674207 . 10.1523/JNEUROSCI.1299-06.2006 . free .
  28. Pfeiffer SE, Warrington AE, Bansal R . The oligodendrocyte and its many cellular processes . Trends in Cell Biology . 3 . 6 . 191–197 . June 1993 . 14731493 . 10.1016/0962-8924(93)90213-K .
  29. Scolding NJ, Rayner PJ, Sussman J, Shaw C, Compston DA . A proliferative adult human oligodendrocyte progenitor . NeuroReport . 6 . 3 . 441–445 . February 1995 . 7766839 . 10.1097/00001756-199502000-00009 .
  30. Zhang SC, Ge B, Duncan ID . Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity . Proceedings of the National Academy of Sciences of the United States of America . 96 . 7 . 4089–4094 . March 1999 . 10097168 . 22425 . 10.1073/pnas.96.7.4089 . free . 1999PNAS...96.4089Z .
  31. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Götz M . Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex . The Journal of Neuroscience . 28 . 41 . 10434–10442 . October 2008 . 18842903 . 6671038 . 10.1523/JNEUROSCI.2831-08.2008 .
  32. Hill RA, Patel KD, Medved J, Reiss AM, Nishiyama A . NG2 cells in white matter but not gray matter proliferate in response to PDGF . The Journal of Neuroscience . 33 . 36 . 14558–14566 . September 2013 . 24005306 . 3761056 . 10.1523/JNEUROSCI.2001-12.2013 .
  33. Káradóttir R, Hamilton NB, Bakiri Y, Attwell D . Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter . Nature Neuroscience . 11 . 4 . 450–456 . April 2008 . 18311136 . 2615224 . 10.1038/nn2060 .
  34. El Waly B, Macchi M, Cayre M, Durbec P . Oligodendrogenesis in the normal and pathological central nervous system . Frontiers in Neuroscience . 8 . 145 . 2014 . 24971048 . 4054666 . 10.3389/fnins.2014.00145 . free .
  35. Hughes EG, Stockton ME . Premyelinating Oligodendrocytes: Mechanisms Underlying Cell Survival and Integration . Frontiers in Cell and Developmental Biology . 9 . 714169 . 2021 . 34368163 . 8335399 . 10.3389/fcell.2021.714169 . free .
  36. Wang H, Rusielewicz T, Tewari A, Leitman EM, Einheber S, Melendez-Vasquez CV . Myosin II is a negative regulator of oligodendrocyte morphological differentiation . Journal of Neuroscience Research . 90 . 8 . 1547–1556 . August 2012 . 22437915 . 3370114 . 10.1002/jnr.23036 .
  37. Tripathi RB, Clarke LE, Burzomato V, Kessaris N, Anderson PN, Attwell D, Richardson WD . Dorsally and ventrally derived oligodendrocytes have similar electrical properties but myelinate preferred tracts . The Journal of Neuroscience . 31 . 18 . 6809–6819 . May 2011 . 21543611 . 4227601 . 10.1523/JNEUROSCI.6474-10.2011 .
  38. Relucio J, Menezes MJ, Miyagoe-Suzuki Y, Takeda S, Colognato H . Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone . Glia . 60 . 10 . 1451–1467 . October 2012 . 22706957 . 5679225 . 10.1002/glia.22365 .
  39. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, Hoang T, Xu X, Mi QS, Xin M, Wang F, Appel B, Lu QR . MicroRNA-mediated control of oligodendrocyte differentiation . Neuron . 65 . 5 . 612–626 . March 2010 . 20223198 . 2855245 . 10.1016/j.neuron.2010.02.018 .
  40. Richardson WD, Young KM, Tripathi RB, McKenzie I . NG2-glia as multipotent neural stem cells: fact or fantasy? . Neuron . 70 . 4 . 661–673 . May 2011 . 21609823 . 3119948 . 10.1016/j.neuron.2011.05.013 .
  41. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE . NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration . Neuron . 68 . 4 . 668–681 . November 2010 . 21092857 . 2989827 . 10.1016/j.neuron.2010.09.009 .
  42. Ffrench-Constant C, Raff MC . Proliferating bipotential glial progenitor cells in adult rat optic nerve . Nature . 319 . 6053 . 499–502 . 1986 . 3945333 . 10.1038/319499a0 . 4254924 . 1986Natur.319..499F .
  43. Zhu X, Bergles DE, Nishiyama A . NG2 cells generate both oligodendrocytes and gray matter astrocytes . Development . 135 . 1 . 145–157 . January 2008 . 18045844 . 10.1242/dev.004895 . free .
  44. Zhu X, Zuo H, Maher BJ, Serwanski DR, LoTurco JJ, Lu QR, Nishiyama A . Olig2-dependent developmental fate switch of NG2 cells . Development . 139 . 13 . 2299–2307 . July 2012 . 22627280 . 3367441 . 10.1242/dev.078873 .
  45. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, Kessaris N, Richardson WD . PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice . Nature Neuroscience . 11 . 12 . 1392–1401 . December 2008 . 18849983 . 3842596 . 10.1038/nn.2220 .
  46. Clarke LE, Young KM, Hamilton NB, Li H, Richardson WD, Attwell D . Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse . The Journal of Neuroscience . 32 . 24 . 8173–8185 . June 2012 . 22699898 . 3378033 . 10.1523/JNEUROSCI.0928-12.2012 .
  47. Tsoa RW, Coskun V, Ho CK, de Vellis J, Sun YE . Spatiotemporally different origins of NG2 progenitors produce cortical interneurons versus glia in the mammalian forebrain . Proceedings of the National Academy of Sciences of the United States of America . 111 . 20 . 7444–7449 . May 2014 . 24799701 . 4034245 . 10.1073/pnas.1400422111 . free . 2014PNAS..111.7444T .
  48. Komitova M, Zhu X, Serwanski DR, Nishiyama A . NG2 cells are distinct from neurogenic cells in the postnatal mouse subventricular zone . The Journal of Comparative Neurology . 512 . 5 . 702–716 . February 2009 . 19058188 . 2614367 . 10.1002/cne.21917 .
  49. Bunge MB, Bunge RP, Ris H . Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord . The Journal of Biophysical and Biochemical Cytology . 10 . 1 . 67–94 . May 1961 . 13688845 . 2225064 . 10.1083/jcb.10.1.67 .
  50. Périer O, Grégoire A . Electron microscopic features of multiple sclerosis lesions . Brain . 88 . 5 . 937–952 . December 1965 . 5864468 . 10.1093/brain/88.5.937 .
  51. Blakemore WF . Pattern of remyelination in the CNS . Nature . 249 . 457 . 577–578 . June 1974 . 4834082 . 10.1038/249577a0 . 4246605 . 1974Natur.249..577B .
  52. Smith KJ, Bostock H, Hall SM . Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline . Journal of the Neurological Sciences . 54 . 1 . 13–31 . April 1982 . 6804606 . 10.1016/0022-510X(82)90215-5 . 2748982 .
  53. Albert M, Antel J, Brück W, Stadelmann C . Extensive cortical remyelination in patients with chronic multiple sclerosis . Brain Pathology . 17 . 2 . 129–138 . April 2007 . 17388943 . 8095564 . 10.1111/j.1750-3639.2006.00043.x . 3158689 .
  54. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH . Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord . The Journal of Neuroscience . 20 . 6 . 2218–2228 . March 2000 . 10704497 . 6772504 . 10.1523/JNEUROSCI.20-06-02218.2000 .
  55. Gensert JM, Goldman JE . Endogenous progenitors remyelinate demyelinated axons in the adult CNS . Neuron . 19 . 1 . 197–203 . July 1997 . 9247275 . 10.1016/s0896-6273(00)80359-1 . free .
  56. Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson WD, Franklin RJ . CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination . Cell Stem Cell . 6 . 6 . 578–590 . June 2010 . 20569695 . 3856868 . 10.1016/j.stem.2010.04.002 .
  57. Zirngibl M, Assinck P, Sizov A, Caprariello AV, Plemel JR . Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination . Molecular Neurodegeneration . 17 . 1 . 34 . May 2022 . 35526004 . 9077942 . 10.1186/s13024-022-00538-8 . free .
  58. McTigue DM, Wei P, Stokes BT . Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord . The Journal of Neuroscience . 21 . 10 . 3392–3400 . May 2001 . 11331369 . 6762495 . 10.1523/JNEUROSCI.21-10-03392.2001 .
  59. Franklin RJ . Why does remyelination fail in multiple sclerosis? . Nature Reviews. Neuroscience . 3 . 9 . 705–714 . September 2002 . 12209119 . 10.1038/nrn917 . 19709750 .
  60. Peru RL, Mandrycky N, Nait-Oumesmar B, Lu QR . Paving the axonal highway: from stem cells to myelin repair . Stem Cell Reviews . 4 . 4 . 304–318 . December 2008 . 18759012 . 10.1007/s12015-008-9043-z . 19055357 .
  61. Chong SY, Chan JR . Tapping into the glial reservoir: cells committed to remaining uncommitted . The Journal of Cell Biology . 188 . 3 . 305–312 . February 2010 . 20142420 . 2819683 . 10.1083/jcb.200905111 .
  62. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, Sprinkle TJ . Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions . Laboratory Investigation; A Journal of Technical Methods and Pathology . 61 . 5 . 489–503 . November 1989 . 2811298 .
  63. Chang A, Tourtellotte WW, Rudick R, Trapp BD . Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis . The New England Journal of Medicine . 346 . 3 . 165–173 . January 2002 . 11796850 . 10.1056/NEJMoa010994 . free .
  64. Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, Nishiyama A . Age-dependent fate and lineage restriction of single NG2 cells . Development . 138 . 4 . 745–753 . February 2011 . 21266410 . 3026417 . 10.1242/dev.047951 .
  65. Sakry D, Yigit H, Dimou L, Trotter J . Oligodendrocyte precursor cells synthesize neuromodulatory factors . PLOS ONE . 10 . 5 . e0127222 . 2015 . 25966014 . 4429067 . 10.1371/journal.pone.0127222 . free . 2015PLoSO..1027222S .
  66. Sakry D, Trotter J . The role of the NG2 proteoglycan in OPC and CNS network function . Brain Research . 1638 . Pt B . 161–166 . May 2016 . 26100334 . 10.1016/j.brainres.2015.06.003 . 32067124 .
  67. Sakry D, Neitz A, Singh J, Frischknecht R, Marongiu D, Binamé F, Perera SS, Endres K, Lutz B, Radyushkin K, Trotter J, Mittmann T . Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2 . PLOS Biology . 12 . 11 . e1001993 . November 2014 . 25387269 . 4227637 . 10.1371/journal.pbio.1001993 . free .
  68. Paez PM, Lyons DA . Calcium Signaling in the Oligodendrocyte Lineage: Regulators and Consequences . Annual Review of Neuroscience . 43 . 163–186 . July 2020 . 32075518 . 10.1146/annurev-neuro-100719-093305 . 211214703 . free .
  69. Kukley M, Capetillo-Zarate E, Dietrich D . Vesicular glutamate release from axons in white matter . Nature Neuroscience . 10 . 3 . 311–320 . March 2007 . 17293860 . 10.1038/nn1850 . 8767161 .
  70. Kukley M, Kiladze M, Tognatta R, Hans M, Swandulla D, Schramm J, Dietrich D . Glial cells are born with synapses . FASEB Journal . 22 . 8 . 2957–2969 . August 2008 . 18467596 . 10.1096/fj.07-090985 . 25966213 . free .
  71. De Biase LM, Nishiyama A, Bergles DE . Excitability and synaptic communication within the oligodendrocyte lineage . The Journal of Neuroscience . 30 . 10 . 3600–3611 . March 2010 . 20219994 . 2838193 . 10.1523/JNEUROSCI.6000-09.2010 .
  72. Kukley M, Nishiyama A, Dietrich D . The fate of synaptic input to NG2 glial cells: neurons specifically downregulate transmitter release onto differentiating oligodendroglial cells . The Journal of Neuroscience . 30 . 24 . 8320–8331 . June 2010 . 20554883 . 6634580 . 10.1523/JNEUROSCI.0854-10.2010 .
  73. Zveik O, Rechtman A, Ganz T, Vaknin-Dembinsky A . The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells . Molecular Neurodegeneration . 19 . 1 . 53 . July 2024 . 38997755 . 11245841 . 10.1186/s13024-024-00742-8 . free .
  74. Haroon A, Seerapu H, Fang LP, Weß JH, Bai X . 2024-07-09 . Unlocking the Potential: immune functions of oligodendrocyte precursor cells . Frontiers in Immunology . English . 15 . 10.3389/fimmu.2024.1425706 . free . 1664-3224. 11263107 .
  75. Moyon S, Dubessy AL, Aigrot MS, Trotter M, Huang JK, Dauphinot L, Potier MC, Kerninon C, Melik Parsadaniantz S, Franklin RJ, Lubetzki C . Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration . The Journal of Neuroscience . 35 . 1 . 4–20 . January 2015 . 25568099 . 6605244 . 10.1523/JNEUROSCI.0849-14.2015 .
  76. Akay LA, Effenberger AH, Tsai LH . Cell of all trades: oligodendrocyte precursor cells in synaptic, vascular, and immune function . Genes & Development . 35 . 3–4 . 180–198 . February 2021 . 33526585 . 7849363 . 10.1101/gad.344218.120 .
  77. Zeis T, Enz L, Schaeren-Wiemers N . The immunomodulatory oligodendrocyte . Brain Research . 1641 . Pt A . 139–148 . June 2016 . 26423932 . 10.1016/j.brainres.2015.09.021 . 33207109 . free .
  78. Falcão AM, van Bruggen D, Marques S, Meijer M, Jäkel S, Agirre E, Floriddia EM, Vanichkina DP, Ffrench-Constant C, Williams A, Guerreiro-Cacais AO, Castelo-Branco G . Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis . Nature Medicine . 24 . 12 . 1837–1844 . December 2018 . 30420755 . 6544508 . 10.1038/s41591-018-0236-y . André Ortlieb . Gonçalo . Charles . Anna . Elisa M. . Darya P. .
  79. Fernández-Castañeda A, Chappell MS, Rosen DA, Seki SM, Beiter RM, Johanson DM, Liskey D, Farber E, Onengut-Gumuscu S, Overall CC, Dupree JL, Gaultier A . The active contribution of OPCs to neuroinflammation is mediated by LRP1 . Acta Neuropathologica . 139 . 2 . 365–382 . February 2020 . 31552482 . 6994364 . 10.1007/s00401-019-02073-1 .
  80. Falcão AM, van Bruggen D, Marques S, Meijer M, Jäkel S, Agirre E, Floriddia EM, Vanichkina DP, Ffrench-Constant C, Williams A, Guerreiro-Cacais AO, Castelo-Branco G . Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis . Nature Medicine . 24 . 12 . 1837–1844 . December 2018 . 30420755 . 6544508 . 10.1038/s41591-018-0236-y .
  81. Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA . Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination . Nature Communications . 10 . 1 . 3887 . August 2019 . 31467299 . 6715717 . 10.1038/s41467-019-11638-3 . 2019NatCo..10.3887K .
  82. Zveik O, Fainstein N, Rechtman A, Haham N, Ganz T, Lavon I, Brill L, Vaknin-Dembinsky A . Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells . Glia . 70 . 6 . 1191–1209 . June 2022 . 35266197 . 9314832 . 10.1002/glia.24165 .
  83. Lakatos A, Franklin RJ, Barnett SC . Olfactory ensheathing cells and Schwann cells differ in their in vitro interactions with astrocytes . Glia . 32 . 3 . 214–225 . December 2000 . 11102963 . 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7 . 25285506 .
  84. Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, Barker GJ, Sillery EL, Sheehan K, Ciccarelli O, Thompson AJ, Brady JM, Matthews PM . Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging . Nature Neuroscience . 6 . 7 . 750–757 . July 2003 . 12808459 . 10.1038/nn1075 . 827480 .
  85. Hirano M, Goldman JE . Gliogenesis in rat spinal cord: evidence for origin of astrocytes and oligodendrocytes from radial precursors . Journal of Neuroscience Research . 21 . 2–4 . 155–167 . 1988 . 3216418 . 10.1002/jnr.490210208 . 43450904 .
  86. Raff MC, Miller RH, Noble M . A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium . Nature . 303 . 5916 . 390–396 . 1983 . 6304520 . 10.1038/303390a0 . 4301091 . 1983Natur.303..390R .
  87. Pringle NP, Mudhar HS, Collarini EJ, Richardson WD . PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage . Development . 115 . 2 . 535–551 . June 1992 . 1425339 . 10.1242/dev.115.2.535 .
  88. Stallcup WB, Beasley L, Levine J . Cell-surface molecules that characterize different stages in the development of cerebellar interneurons . Cold Spring Harbor Symposia on Quantitative Biology . 48 . Pt 2 . 761–774 . 1983 . 6373111 . 10.1101/sqb.1983.048.01.078 .
  89. Stallcup WB, Cohn M . Electrical properties of a clonal cell line as determined by measurement of ion fluxes . Experimental Cell Research . 98 . 2 . 277–284 . March 1976 . 943300 . 10.1016/0014-4827(76)90439-0 .
  90. Wilson SS, Baetge EE, Stallcup WB . Antisera specific for cell lines with mixed neuronal and glial properties . Developmental Biology . 83 . 1 . 146–153 . April 1981 . 6263737 . 10.1016/s0012-1606(81)80017-6 .
  91. Shaĭtan KV, Ermolaeva MD, Saraĭkin SS . [Molecular dynamics of oligopeptides. 3. Maps of levels of free energy of modified dipeptides and dynamic correlation in amino acid residues] . Biofizika . 44 . 1 . 18–21 . 1999 . 10330580 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Oligodendrocyte progenitor cell".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.